Cargando…

Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy

Detalles Bibliográficos
Autores principales: Niscola, Pasquale, Tendas, Andrea, Scaramucci, Laura, Merola, Roberta, Catalano, Gianfranco, de Fabritiis, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090335/
https://www.ncbi.nlm.nih.gov/pubmed/25025016
http://dx.doi.org/10.5045/br.2014.49.2.130
_version_ 1782480614049447936
author Niscola, Pasquale
Tendas, Andrea
Scaramucci, Laura
Merola, Roberta
Catalano, Gianfranco
de Fabritiis, Paolo
author_facet Niscola, Pasquale
Tendas, Andrea
Scaramucci, Laura
Merola, Roberta
Catalano, Gianfranco
de Fabritiis, Paolo
author_sort Niscola, Pasquale
collection PubMed
description
format Online
Article
Text
id pubmed-4090335
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-40903352014-07-14 Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy Niscola, Pasquale Tendas, Andrea Scaramucci, Laura Merola, Roberta Catalano, Gianfranco de Fabritiis, Paolo Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014-06 2014-06-25 /pmc/articles/PMC4090335/ /pubmed/25025016 http://dx.doi.org/10.5045/br.2014.49.2.130 Text en © 2014 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Niscola, Pasquale
Tendas, Andrea
Scaramucci, Laura
Merola, Roberta
Catalano, Gianfranco
de Fabritiis, Paolo
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
title Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
title_full Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
title_fullStr Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
title_full_unstemmed Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
title_short Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
title_sort long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090335/
https://www.ncbi.nlm.nih.gov/pubmed/25025016
http://dx.doi.org/10.5045/br.2014.49.2.130
work_keys_str_mv AT niscolapasquale longtermhematologicalresponseinapatientwith5qsyndromeaftersuspensionoflenalidomidetherapyandfurtherimprovementwithdeferasiroxtherapy
AT tendasandrea longtermhematologicalresponseinapatientwith5qsyndromeaftersuspensionoflenalidomidetherapyandfurtherimprovementwithdeferasiroxtherapy
AT scaramuccilaura longtermhematologicalresponseinapatientwith5qsyndromeaftersuspensionoflenalidomidetherapyandfurtherimprovementwithdeferasiroxtherapy
AT merolaroberta longtermhematologicalresponseinapatientwith5qsyndromeaftersuspensionoflenalidomidetherapyandfurtherimprovementwithdeferasiroxtherapy
AT catalanogianfranco longtermhematologicalresponseinapatientwith5qsyndromeaftersuspensionoflenalidomidetherapyandfurtherimprovementwithdeferasiroxtherapy
AT defabritiispaolo longtermhematologicalresponseinapatientwith5qsyndromeaftersuspensionoflenalidomidetherapyandfurtherimprovementwithdeferasiroxtherapy